Udagawa Y - Search Results

1

Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer.

Aoki D, Watanabe Y, Jobo T, Ushijima K, Hasegawa K, Susumu N, Suzuki N, Aoki R, Isonishi S, Sagae S, Ishizuka B, Kamura T, Udagawa Y, Hoshiai H, Ohashi Y, Ochiai K, Noda K. Aoki D, et al. Among authors: udagawa y. Anticancer Res. 2009 Feb;29(2):561-6. Anticancer Res. 2009. PMID: 19331203 Free article. Clinical Trial.

2

Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.

Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R; Japanese Gynecologic Oncology Group. Susumu N, et al. Among authors: udagawa y. Gynecol Oncol. 2008 Jan;108(1):226-33. doi: 10.1016/j.ygyno.2007.09.029. Epub 2007 Nov 9. Gynecol Oncol. 2008. PMID: 17996926 Clinical Trial.

3

Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.

Ohie S, Udagawa Y, Kozu A, Komuro Y, Aoki D, Nozawa S, Moossa AR, Hoffman RM. Ohie S, et al. Among authors: udagawa y. Anticancer Res. 2000 May-Jun;20(3B):2049-54. Anticancer Res. 2000. PMID: 10928150

4

[Treatment for recurrent ovarian cancer].

Hasegawa K, Torii H, Ooe S, Udagawa Y. Hasegawa K, et al. Among authors: udagawa y. Gan To Kagaku Ryoho. 2009 Feb;36(2):230-6. Gan To Kagaku Ryoho. 2009. PMID: 19263612 Japanese. No abstract available.

5

[Treatment outcomes for advanced ovarian cancers with peritoneal dissemination].

Oe S, Hasegawa K, Ichikawa R, Torii Y, Kato R, Komiyama S, Udagawa Y. Oe S, et al. Among authors: udagawa y. Gan To Kagaku Ryoho. 2011 Apr;38(4):591-7. Gan To Kagaku Ryoho. 2011. PMID: 21498987 Japanese.

6

ERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cells.

Torii Y, Kato R, Minami Y, Hasegawa K, Fujii T, Udagawa Y. Torii Y, et al. Among authors: udagawa y. Anticancer Res. 2014 Jan;34(1):107-15. Anticancer Res. 2014. PMID: 24403450

7

Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase.

Saitoh E, Aoki D, Susumu N, Udagawa Y, Nozawa S. Saitoh E, et al. Among authors: udagawa y. Int J Oncol. 2003 Aug;23(2):303-10. Int J Oncol. 2003. PMID: 12851678

8

Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation.

Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y, Nozawa S. Komiyama S, et al. Among authors: udagawa y. Gynecol Oncol. 1999 Mar;72(3):342-6. doi: 10.1006/gyno.1998.5284. Gynecol Oncol. 1999. PMID: 10053105

9

[Dose finding study of paclitaxel and carboplatin for ovarian cancer (JKTB)].

Yasuda M, Kimura E, Ochiai K, Tada S, Udagawa Y, Aoki D, Nozawa S, Kikuchi Y, Kita T, Nishida M, Tsunoda H. Yasuda M, et al. Among authors: udagawa y. Gan To Kagaku Ryoho. 2001 Apr;28(4):493-8. Gan To Kagaku Ryoho. 2001. PMID: 11329783 Clinical Trial. Japanese.

10

Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin.

Komuro Y, Udagawa Y, Susumu N, Aoki D, Kubota T, Nozawa S. Komuro Y, et al. Among authors: udagawa y. Jpn J Cancer Res. 2001 Nov;92(11):1242-50. doi: 10.1111/j.1349-7006.2001.tb02146.x. Jpn J Cancer Res. 2001. PMID: 11714450 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters